A formalin inactivated whole SIV vaccine and a glycoprotein-enriched subunit vaccine confers protection against experimental challenge with pathogenic live SIV in rhesus monkeys.
Murphey-Corb
M
M
Delta Primate Center, Tulane University, Covington.
Martin
L N
LN
Davison-Fairburn
B
B
Montelaro
R C
RC
Miller
M
M
West
M
M
Ohkawa
S
S
Baskin
G B
GB
Zhang
J Y
JY
Putney
S
S
D000818:Animals; D000914:Antibodies, Viral / Q000096:biosynthesis; D002846:Chromatography, Affinity; D015925:Cryopreservation; D004195:Disease Models, Animal; D005557:Formaldehyde; D006023:Glycoproteins / Q000276:immunology; D007117:Immunization, Secondary; D008253:Macaca mulatta; D016097:Simian Acquired Immunodeficiency Syndrome / Q000517:prevention & control*; D015302:Simian Immunodeficiency Virus / Q000276:immunology*; D015164:Vaccines, Inactivated; D014764:Viral Proteins / Q000276:immunology; D014765:Viral Vaccines
D000914:Antibodies, Viral; D006023:Glycoproteins; D015164:Vaccines, Inactivated; D014764:Viral Proteins; D014765:Viral Vaccines; D005557:Formaldehyde